John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs

A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Related Posts

Regulations of crypto

Cryptocurrency Regulations Worldwide

How Countries Are Shaping the Future of Digital Currencies Cryptocurrencies have revolutionized the global financial landscape, offering decentralized alternatives to traditional banking systems. But as